Clinical Practice Guideline

ESMO Updated Clinical Practice Guideline for Oncogene-Addicted Metastatic NSCLC

ESMO – European Society for Medical Oncology shared a post on LinkedIn:

“Updated ESMO Clinical Practice Guideline recommendations in oncogene-addicted metastatic NSCLC: more Targeted Therapy agents now available in 1L or at resistance.”

Read further.

More posts featuring ESMO on OncoDaily.

cancer ESMO ESMO Clinical Practice Guideline European Society for Medical Oncology NSCLC OncoDaily oncoology targeted therapy